Use of tumor necrosis factor in isolated hepatic perfusion.
Fraker
D L
DL
Surgical Metabolism Section, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892-1502, USA.
Alexander
H R
HR
Thom
A K
AK
D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D006224:Cricetinae; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000556:secondary; D008545:Melanoma / Q000188:drug therapy; D008558:Melphalan / Q000627:therapeutic use; D010477:Perfusion; D014409:Tumor Necrosis Factor-alpha / Q000008:administration & dosage* / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D014409:Tumor Necrosis Factor-alpha; D008558:Melphalan